[CTLT] Catalent, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization: 2.96 B

Exchange: NYSE

The data is delayed by 15 minutes.

 

Price: 26.9 Change: 0.56 (2.13%)
Ext. hours: Change: 0 (0%)

chart CTLT

Refresh chart

Strongest Trends Summary For CTLT

CTLT is in the medium-term up 36% in 2 months. In the long-term up 73% in 4 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. It operates through three segments: Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment provides advanced oral delivery technologies, including formulation, development, and manufacturing of oral dose forms for prescription and consumer health products. This segment?s oral dose forms include soft gel, modified release technologies, and immediate release solid oral products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development & Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. This segment also offers analytical chemical and cell-based testing and scient

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding124.71 M EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -14.05% Sales Growth - Q/Q-2.02% P/E
P/E To EPS Growth P/S1.61 P/BV6.33 Price/Cash Per Share
Price/Free Cash Flow53.01 ROA2.88% ROE18.13% ROI3.43%
Current Ratio1.79 Quick Ratio1.4 Long Term Debt/Equity6.45 Debt Ratio0.77
Gross Margin33.9% Operating Margin14.77% Net Profit Margin4.66% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities209 M Cash From Investing Activities-240.3 M Cash From Operating Activities94.7 M Gross Profit152.2 M
Net Profit31.5 M Operating Profit65.8 M Total Assets2.97 B Total Current Assets653.1 M
Total Current Liabilities365.4 M Total Debt1.88 B Total Liabilities2.51 B Total Revenue446.6 M
Technical Data
High 52 week46.34 Low 52 week29.84 Last close43.42 Last change-0.37%
RSI94.06 Average true range1.06 Beta1.09 Volume419.58 K
Simple moving average 20 days8.69% Simple moving average 50 days20.97% Simple moving average 200 days9.22%
Performance Data
Performance Week3.31% Performance Month21.97% Performance Quart15.48% Performance Half3.5%
Performance Year2.36% Performance Year-to-date39.26% Volatility daily1.16% Volatility weekly2.59%
Volatility monthly5.32% Volatility yearly18.41% Relative Volume271.85% Average Volume1.01 M
New High New Low

News

2019-03-15 09:30:01 | CTLT or NBIX: Which Is the Better Value Stock Right Now?

2019-03-07 06:07:06 | Is Catalent, Inc.’s NYSE:CTLT Balance Sheet A Threat To Its Future?

2019-03-06 16:15:00 | Catalent, Inc. to Present at the Barclays Global Healthcare Conference

2019-03-04 23:40:04 | Champions Oncology CSBR Q3 Earnings: What's in Store?

2019-02-27 09:57:02 | The Zacks Analyst Blog Highlights: Celgene, Charles River Laboratories International, Catalent and Aeterna Zentaris

2019-02-26 08:55:01 | 4 Drug Stocks to Buy Despite Price Hearing Woes

2019-02-15 08:16:01 | Will Catalent Continue to Surge Higher?

2019-02-13 07:00:00 | Catalent Names Alessandro Maselli President and Chief Operating Officer

2019-02-12 09:30:02 | CTLT vs. NBIX: Which Stock Should Value Investors Buy Now?

2019-02-08 08:07:11 | See what the IHS Markit Score report has to say about Catalent Inc.

2019-02-05 14:50:57 | Edited Transcript of CTLT earnings conference call or presentation 5-Feb-19 1:15pm GMT

2019-02-05 12:55:19 | Catalent Inc CTLT Q2 2019 Earnings Conference Call Transcript

2019-02-05 08:55:01 | Catalent CTLT Beats Q2 Earnings and Revenue Estimates

2019-02-05 07:52:35 | Catalent: Fiscal 2Q Earnings Snapshot

2019-02-05 07:30:00 | Catalent, Inc. Reports Second Quarter Fiscal 2019 Results

2019-01-29 10:31:03 | Analysts Estimate Catalent CTLT to Report a Decline in Earnings: What to Look Out for

2019-01-29 08:03:11 | See what the IHS Markit Score report has to say about Catalent Inc.

2019-01-28 07:55:00 | Investor Expectations to Drive Momentum within Cognizant Technology Solutions, Public Service Enterprise Group, Iron Mountain, Catalent, QuinStreet, and Entravision Communications — Discovering Underlying Factors of Influence

2019-01-26 08:12:01 | A Closer Look At Catalent, Inc.’s NYSE:CTLT Uninspiring ROE

2019-01-15 08:03:33 | See what the IHS Markit Score report has to say about Catalent Inc.

2019-01-14 16:15:00 | Catalent, Inc. Announces Second Quarter Fiscal Year 2019 Earnings Conference Webcast

2019-01-09 08:03:55 | See what the IHS Markit Score report has to say about Catalent Inc.

2019-01-08 14:52:03 | Catalent to expand Wisconsin biomanufacturing operation

2019-01-07 07:00:00 | Catalent Invests $200 Million to Expand Biologics Capacity and Capabilities

2018-12-27 09:23:36 | Stocks down in December for pharma firms in the Triangle

2018-12-19 16:15:00 | Catalent, Inc. to Present at the 37th Annual J.P. Morgan Health Care Conference

2018-12-12 00:20:39 | Is Catalent Inc CTLT A Good Stock To Buy?

2018-12-10 09:29:02 | Moving Average Crossover Alert: Catalent

2018-12-03 03:00:00 | Biohaven Delivers Positive Phase 3 Results with Rimegepant Zydis® Orally Dissolving Tablet ODT: Rapid and Lasting Benefit for the Acute Treatment of Migraine

2018-11-28 09:15:02 | Stocks Hold Onto Gains Ahead of Powell Speech

2018-11-09 08:02:09 | See what the IHS Markit Score report has to say about Catalent Inc.

2018-11-07 07:21:31 | What Does Catalent Inc’s NYSE:CTLT P/E Ratio Tell You?

2018-11-06 13:30:53 | Edited Transcript of CTLT earnings conference call or presentation 6-Nov-18 1:15pm GMT

2018-11-06 11:47:03 | Catalent Inc CTLT Q1 2019 Earnings Conference Call Transcript

2018-11-06 07:48:29 | Catalent: Fiscal 1Q Earnings Snapshot

2018-11-06 07:30:00 | Catalent, Inc. Reports First Quarter Fiscal 2019 Results

2018-11-06 06:37:42 | Is Catalent Inc’s NYSE:CTLT CEO Incentives Align With Yours?

2018-10-31 16:15:00 | Catalent, Inc. to Present at Three Upcoming Investor Conferences

2018-10-23 07:45:00 | Report: Exploring Fundamental Drivers Behind The Home Depot, uniQure N.V, Catalent, Apple, BioTime, and PDL BioPharma — New Horizons, Emerging Trends, and Upcoming Developments

2018-10-20 08:05:22 | See what the IHS Markit Score report has to say about Catalent Inc.

2018-10-18 08:05:23 | See what the IHS Markit Score report has to say about Catalent Inc.

2018-10-16 08:05:37 | See what the IHS Markit Score report has to say about Catalent Inc.

2018-10-11 08:17:25 | See what the IHS Markit Score report has to say about Catalent Inc.

2018-10-08 16:15:00 | Catalent, Inc. Announces First Quarter Fiscal Year 2019 Earnings Conference Webcast

2018-10-08 08:05:33 | See what the IHS Markit Score report has to say about Catalent Inc.

2018-10-03 20:15:17 | Catalent Inc CTLT Chair, President & CEO John R Chiminski Sold $5.9 million of Shares

2018-09-19 07:12:11 | New Strong Sell Stocks for September 19th

2018-09-13 08:04:14 | See what the IHS Markit Score report has to say about Catalent Inc.

2018-09-04 08:04:59 | See what the IHS Markit Score report has to say about Catalent Inc.

2018-08-28 14:06:30 | Edited Transcript of CTLT earnings conference call or presentation 28-Aug-18 12:15pm GMT